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April 20121158 Matos et algroups recommend the use of thrombolytic agents in a
selective group of patients who do not respond to systemic
heparin anticoagulation.19,20 Criticism of conservative
management includes the possibility of developing com-
partment syndrome and limb length discrepancies.3,9,11
In the infant population, supportive care and the use of
systemic anticoagulation with heparin is the best manage-
ment for most patients. Limb viability was 100% in this
series of infants with ALI managed nonoperatively, and we
propose that favorable remodeling in parallel collateral
vessels occurs due to changes in flow dynamics with acute
occlusion. Our recommendation for infants presenting
with ALI is physical examination followed by DUS and
systemic anticoagulation with heparin and transitioned to
SQ lovenox. Patients should undergo serial examinations
to assess changes in perfusion of the index limb and a repeat
DUS in 3 to 4 weeks. We further recommend that if
adequate perfusion of the limb is established by examina-
tion and DUS, then anticoagulation should be stopped.
During the observational period, it is important for the
vascular surgeon to establish expectations with the family.
It is important to warn the family that the child could suffer
limb discrepancies. If DUS depicts restoration of flow with
collateral formation, anticoagulation can be stopped. Sur-
gical intervention is indicated in patients with tissue loss,
active bleeding, or lack of response to systemic anticoagu-
lation.
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Dr George Hamilton (London, United Kingdom). Congrat-
ulations on your results; we have a similar experience. What you
haven’t mentioned is thrombolysis. As a tertiary referral center, a
lot of our children get to us late, having been treated at other
hospitals. Our protocol is to start with anticoagulation absolutely
monitored with APTT for a period of 6 hours or so. If that doesn’t
improve perfusion, systemic thrombolysis is then used. There is a
risk, particularly in preterm infants, of cerebral hemorrhage, but
that risk actually is worth taking because the results of thrombolysis
are universally good except in irreversible ischemia. We would
agree absolutely that there is really a very little role for surgical
intervention because the results are dreadful.
Dr Jesus Matos. The one patient that underwent thrombec-
tomy was transferred from an outside institution, and by the time
he got to our institution, it was too late to consider thrombolysis.n adequate option. Unfortunately, in our series we don’t have any
ids that underwent thrombolysis treatment.
Dr Jonathan Beard (Sheffield, United Kingdom): I’d like to
oncur with not operating on these babies. My experience with
wo have been disastrous. It’s like operating on a piece of wet tissue
aper.
I’m a bit worried about your suggestion that you should wait.
ou seem to suggest that it is best to wait until the limb is going
lack before you intervene. Have you thought about other meth-
ds of monitoring limb perfusion, maybe compartment pressures,
or instance, to see if the compartment pressure is going up? That
ight be an indication for the need for intervention.
Dr Matos. We did not measure compartment pressures on
ny of our patients. We feel that very close monitoring of these kids
y the vascular team several times a day is sufficient.Dr Beard. What features on physical examination do you use
o determine intervention?
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Volume 55, Number 4 Matos et al 1159Dr Matos. Rutherford Class 3 with gangrene and extensive
tissue loss. I agree, it’s difficult, because you don’t have the ability
to check whether the kid has sensation, whether they’re able to
move on command, so it is a little more challenging in that sense.
Dr William Turnipseed (Madison, Wisc). I have some anec-
dotal experience that really predates the more current thrombo-
lytic and antiplatelet medications. I have three patients that I’ve
actually followed for almost 20 years. One of my questions will be:
Do you have any examples of pediatric infant injuries that predate
your study to give you longer follow-up? Because the real critical
issue is not what happens in the first 3 months, but for the
survivors, information relative to their lifestyle and any morbidity
down the road.
I can tell you that from my experience, I had three cases that
extended over about a 6-year period. They were all very similar.
They were all cardiac cases. In each case, a cardiac catheter had
knotted in the common iliac, and the external iliac was totally
evulsed and pulled out through the groin. This really taught me a
lesson, and that is, that if the hypogastric is open and the profunda
is open, that anticoagulation actually stands a very good chance of
working on these patients.
The long-term follow-up has been very interesting. I would
have suspected some limb deformity. Your point about generous
collateral development in the very young is quite accurate in that all
three of these have grown up with normal leg length and normal
leg function, after 2 decades of follow-up.
Dr Matos. Thank you for your comments. Actually, Dr
Dalsing knows, by name, every single patient in this study because
he’s been following them very extensively. Unfortunately, it’s
difficult for us to follow some of these kids long-term because we
are the only tertiary center in the state of Indiana, and a lot of these
kids come from out of town. And a lot of time, the follow-up is
i
tased on what the primary care surgeon tells us over the phone.
ut from what we can tell, Dr Dalsing has been following the
ongest kid for about 6 years now with no limb discrepancies.
Dr Timothy Baxter (Omaha, Neb). My question is about
asciotomies. I’ve had a hard time making that decision in some of
hese kids. I’ve watched their CPK levels because the physical
xamination may be hard to interpret. In seeing them back in
ollow-up, I have seen some gait abnormalities. So the question is,
ow do you decide about whether to perform a fasciotomy?
Dr Matos. The one kid that we performed the open throm-
ectomy with the fasciotomy had very severe tissue loss with
angrene and had been mismanaged by the outside institution for
ver 12 hours, so the decision for us to perform the fasciotomy was
retty straightforward. But it is difficult to come to that decision, I
gree.
Dr Malachi Sheahan (New Orleans, La). Since what you’re
escribing is the treatment of iatrogenic injuries to the common
emoral artery rather than congenital anomalies, I think it would be
seful if you expanded the group to include children up to 4 or 5
ears of age. Dr Lumsden has one of the largest reported series in
hich he manages these children fairly aggressively, a lot of them
ith bypass. Overall, however, the literature suffers from a lack of
umbers. So if you have more cases to add to the worldwide
xperience, I’d be interested to see what happens with these kids
p to 2, 3, 4 years old, especially with regard to limb length and
unctional development.
DrMatos. I agree. Most of the literature out there, including
r Lumsden’s and Dr Lin’s publication, is from kids 2 years of
ge that were managed surgically. There is a greater correlation of
imb length discrepancy in that age group, but there is not as much
n kids younger than 2, which is why we were interested in studying
his age group.
